Public leery of third-party partnerships

Share this article:
A survey of public attitudes toward drug company partnerships with nonprofits has found skepticism of industry motives.

Among respondents to the Envision Solutions survey, 43% said pharmas fund groups like the American Heart Association and the National Kidney Foundation primarily to boost sales of their medicines.

The survey suggests a hardening of attitudes toward such partnerships. By contrast, only 10% of respondents to a similar question in a PRWeek/Barkley Public Relations poll last year said pharmas partner with non-profits primarily to boost profits.

Envision Solutions pointed to media coverage of “disease mongering” as a likely factor driving cynicism. The consultancy said the number of reports on that topic increased 775% from 2005 to 2006.

The online survey of 1,062 US adults was conducted by polling firm Kelton Research from April 10-13.

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union